Back

Avocado supplementation mitigates hypertension and multi-organ injury in an L-NAME model of cardiovascular dysfunction

Amadi, J. A.; Aloy-Amadi, O. C.; Chukwuma, C. H.; Amadi, P.

2025-10-13 physiology
10.1101/2025.10.10.681766 bioRxiv
Show abstract

BackgroundEndothelial dysfunction, hypertension, and multi-organ injury remain central drivers of cardiovascular disease. Avocado (Persea americana) is rich in monounsaturated fatty acids, phytosterols, and antioxidants, yet its integrative impact on hypertension-induced systemic injury has not been fully explored. MethodsMale Wistar rats (n = 4/group) were randomized into six groups: control, avocado, L-NAME, L-NAME+losartan+metaprolol succinate, L-NAME+avocado, and L-NAME+metaprolol succinate+avocado. Avocado pulp was incorporated into diet at 80% w/w. Endpoints included blood pressure indices, hematological parameters, liver enzymes, renal function tests, and correlation analyses of systolic-diastolic coupling. One-way ANOVA with Tukeys post hoc tests evaluated group differences, while forest plots and scatter analyses visualized treatment effects. ResultsL-NAME significantly elevated systolic blood pressure ({Delta}+18 mmHg), diastolic pressure ({Delta}+20 mmHg), and mean arterial pressure ({Delta}+17 mmHg; all p < 0.01) compared with controls. Avocado supplementation reduced these elevations by ~15-18 mmHg, restoring values near baseline. L-NAME increased platelet counts (p = 0.031) and trended toward leukocytosis, both of which were attenuated by avocado. ALT levels were higher in L-NAME rats (p = 0.044), while AST and ALP trended upward; avocado-fed groups maintained near-control enzyme levels. Renal markers were most affected: urea (+25 mg/dl) and creatinine (+0.8 mg/dl) rose significantly in L-NAME rats (p < 0.01), but were reduced by 20-30% with avocado supplementation. Electrolytes remained unchanged. Correlation analyses revealed pathological SBP-DBP coupling in L-NAME rats (r = 0.78), abolished by avocado (r = 0.00). ConclusionAvocado supplementation mitigates L-NAME-induced hypertension and systemic injury by stabilizing blood pressure, reducing thrombocytosis, and preserving hepatic and renal function. These findings support avocado as a pleiotropic nutraceutical adjunct for cardiometabolic protection. HighlightsO_LIAvocado pulp supplementation incorporated into chow (80% w/w) mitigates L-NAME-induced hypertension in rats. C_LIO_LIDietary avocado preserves hepatic and renal biochemical function while reducing thrombocytosis under cardiovascular stress. C_LIO_LIAvocado demonstrates pleiotropic nutraceutical potential, stabilizing systemic physiology beyond conventional pharmacological therapy. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=106 SRC="FIGDIR/small/681766v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@101b300org.highwire.dtl.DTLVardef@8f0624org.highwire.dtl.DTLVardef@1dc4ab3org.highwire.dtl.DTLVardef@1ac4130_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of the American Heart Association
119 papers in training set
Top 0.1%
23.6%
2
American Journal of Physiology-Heart and Circulatory Physiology
32 papers in training set
Top 0.1%
19.6%
3
Hypertension
32 papers in training set
Top 0.1%
7.1%
50% of probability mass above
4
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 0.6%
5.1%
5
PLOS ONE
4510 papers in training set
Top 33%
4.5%
6
BMJ Open Diabetes Research & Care
15 papers in training set
Top 0.3%
3.8%
7
Physiological Reports
35 papers in training set
Top 0.2%
2.7%
8
Cardiovascular Research
33 papers in training set
Top 0.4%
1.8%
9
Frontiers in Physiology
93 papers in training set
Top 3%
1.4%
10
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1%
1.4%
11
Atherosclerosis
29 papers in training set
Top 0.8%
1.4%
12
Function
15 papers in training set
Top 0.3%
1.3%
13
Scientific Reports
3102 papers in training set
Top 68%
1.2%
14
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.0%
15
Antioxidants
25 papers in training set
Top 0.3%
1.0%
16
The Journal of Physiology
134 papers in training set
Top 1%
0.9%
17
eLife
5422 papers in training set
Top 52%
0.9%
18
Circulation
66 papers in training set
Top 2%
0.8%
19
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
20
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.8%
21
Diabetes, Obesity and Metabolism
17 papers in training set
Top 0.4%
0.8%
22
BioMed Research International
25 papers in training set
Top 3%
0.8%
23
Open Heart
19 papers in training set
Top 1%
0.8%
24
Circulation Research
39 papers in training set
Top 1.0%
0.8%
25
American Journal of Physiology-Renal Physiology
25 papers in training set
Top 0.2%
0.8%
26
Life Sciences
25 papers in training set
Top 1%
0.8%
27
Acta Physiologica
13 papers in training set
Top 0.4%
0.5%
28
Nutrients
64 papers in training set
Top 2%
0.5%